IRCT20200408046990N2招募中3 期
Evaluation of colchicine tablet efficacy as an adjuvant treatment for patients with mild to moderate COVID-19 in Qaem Hospital, Mashhad: A triple-blind randomized placebo controlled clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 85 years（—）
- 性别
- All
入选标准
- •Clinical or laboratory diagnosis of mild to moderate covid-19
- •age between 18-85 y
- •sign of written consent
排除标准
- •use of protease inhibitors like kaletra
- •history of allergy to colchicine
- •pregnancy and lactation
- •hepatic failure (child pugh C), kidney failure (GFR<30 ml/min), or heart failure with EF<40%
- •concomitant use of CYP3A4 or pgp potent inhibitors or inducers
- •concomitant use of statins except rosuvastatin
- •active GI disturbances like active peptic ulcers
- •transmission of patients to ICU ward or his/her intubation
- •patients on colchicine for behcet disease or Mediterranean fever or gout
- •patients with history of neuromuscular disease or chronic diarrhea or malabsorption
研究者
相似试验
已完成
Unknown
Efficacy Evaluation of SupplementAdultJPRN-UMIN000049332Research Center for Immunological Analysis, Inc.11
已完成
不适用
Clinical study to evaluate the efficacy, pharmacokinetics and safety of immunoglobulin intravenous (human) 10% (NewGam) in patients with primary immunodeficiency diseasesCommon variable immunodeficiencyPrimary immunodeficiency diseases (PID)Haematological DisordersISRCTN05425999Octapharma AG (Switzerland)50
已完成
2 期
Comparison of efficacy of oral Levamisole and Formoterol+Budesonide inhaler with standard treatment of Corona infection.IRCT20200324046852N1Fasa University of Medical Sciences30
已完成
不适用
Comprehension of exercises and electrical stimulation on elderly hyperkyphosisHyperkyphosis.IRCT2017060634351N1Investigator45
进行中（未招募）
不适用
Study to evaluate the efficacy, metabolism and safety of human immune globulin in patients with primary immunodeficiency diseases.EUCTR2009-011434-10-Outside-EU/EEAOCTAPHARMA AG51